Additional Paid in Capital of Odyssey Health, Inc. from 31 Jul 2014 to 31 Jan 2026

Taxonomy & unit
us-gaap: USD
Description
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
Summary
Odyssey Health, Inc. quarterly Additional Paid in Capital in USD history and change rate from 31 Jul 2014 to 31 Jan 2026.
  • Odyssey Health, Inc. Additional Paid in Capital for the quarter ending 31 Jan 2026 was $56,135,234, a 0.81% increase year-over-year.
Source SEC data
View on sec.gov
Additional Paid in Capital, Quarterly (USD)
Additional Paid in Capital, YoY Quarterly Change (%)

Odyssey Health, Inc. Quarterly Additional Paid in Capital (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $56,135,234 +$452,586 +0.81% 31 Jan 2026 10-Q 12 Mar 2026 2026 Q2
Q3 2025 $55,974,242 +$327,725 +0.59% 31 Oct 2025 10-Q 11 Dec 2025 2026 Q1
Q2 2025 $55,694,429 +$121,742 +0.22% 31 Jul 2025 10-Q 12 Mar 2026 2026 Q2
Q1 2025 $55,694,429 -$352,405 -0.63% 30 Apr 2025 10-Q 13 Jun 2025 2025 Q3
Q4 2024 $55,682,648 -$314,629 -0.56% 31 Jan 2025 10-Q 14 Mar 2025 2025 Q2
Q3 2024 $55,646,517 +$1,311,114 +2.4% 31 Oct 2024 10-Q 16 Dec 2024 2025 Q1
Q2 2024 $55,572,687 +$1,710,309 +3.2% 31 Jul 2024 10-K 29 Oct 2025 2025 FY
Q1 2024 $56,046,834 +$2,661,807 +5% 30 Apr 2024 10-Q 14 Jun 2024 2024 Q3
Q4 2023 $55,997,277 +$3,440,604 +6.5% 31 Jan 2024 10-Q 22 Mar 2024 2024 Q2
Q3 2023 $54,335,403 +$3,463,661 +6.8% 31 Oct 2023 10-Q 15 Dec 2023 2024 Q1
Q2 2023 $53,862,378 +$4,405,902 +8.9% 31 Jul 2023 10-K 13 Nov 2024 2024 FY
Q1 2023 $53,385,027 +$5,375,560 +11% 30 Apr 2023 10-Q 14 Jun 2023 2023 Q3
Q4 2022 $52,556,673 +$7,743,742 +17% 31 Jan 2023 10-Q 17 Mar 2023 2023 Q2
Q3 2022 $50,871,742 +$6,578,430 +15% 31 Oct 2022 10-Q 14 Dec 2022 2023 Q1
Q2 2022 $49,456,476 +$6,577,198 +15% 31 Jul 2022 10-K 30 Oct 2023 2023 FY
Q1 2022 $48,009,467 30 Apr 2022 10-Q 14 Jun 2022 2022 Q3
Q4 2021 $44,812,931 31 Jan 2022 10-Q 15 Mar 2022 2022 Q2
Q3 2021 $44,293,312 31 Oct 2021 10-Q 10 Dec 2021 2022 Q1
Q2 2021 $42,879,278 31 Jul 2021 10-K 31 Oct 2022 2022 FY
Q1 2019 $263,069 +$163,009 +163% 30 Apr 2019 10-Q 07 Jun 2019 2019 Q3
Q2 2018 $192,086 -$54,867,914 -100% 31 Jul 2018 10-Q 07 Jun 2019 2019 Q3
Q1 2018 $100,060 30 Apr 2018 10-Q 07 Aug 2018 2018 Q3
Q4 2017 $100,060 31 Jan 2018 10-Q 30 May 2018 2018 Q2
Q3 2017 $55,060,000 +$55,027,250 31 Oct 2017 10-Q 20 Dec 2017 2018 Q1
Q2 2017 $55,060,000 +$55,027,250 31 Jul 2017 10-Q 07 Aug 2018 2018 Q3
Q3 2016 $32,750* $0 31 Oct 2016 10-Q 20 Dec 2016 2017 Q1
Q2 2016 $32,750* $0 31 Jul 2016 10-Q 20 Dec 2016 2017 Q1
Q1 2016 $32,750* 30 Apr 2016 10-Q 16 Jun 2016 2016 Q3
Q4 2015 $32,750* 31 Jan 2016 10-Q 15 Mar 2016 2016 Q2
Q3 2015 $32,750* 31 Oct 2015 10-Q 22 Dec 2015 2016 Q1
Q2 2015 $32,750* $0 31 Jul 2015 10-K 02 Nov 2016 2016 FY
Q2 2014 $32,750* 31 Jul 2014 10-K 01 Dec 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.